AVIR
Atea
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
AVIR Profile
Atea Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company developing antiviral therapies for severe respiratory diseases, including COVID-19
225 Franklin Street, Suite 2100, Boston, MA 02110
--
Atea Pharmaceuticals, Inc., was incorporated in July 2012 and commenced primary operations in March 2014. The company is a clinical-stage biopharmaceutical company that discovers and develops novel oral product candidates for the treatment of serious viral diseases using a deep understanding of antiviral drug development, medicinal chemistry, biology, biochemistry and virology.